Objectives This study was conducted to determine the prevalence of and associated risk factors for infection with oral high-risk human papillomavirus (HR-HPV) in adult participants within England, and to explore any association with oral mucosal buccal epithelial cell and whole blood folate concentration.
INTRODUCTION
Rates of oropharyngeal cancer (OPC) are increasing worldwide, attributable to an increase in the incidence of oral infection with high-risk human papillomavirus (HR-HPV). 1 There are large geographical variations in the proportion of OPC cases associated with HPV infection; a recent study found 59.3% of North American, 31.1% of European and just 4.1% of South American OPC samples were positive for HPV16. 2 Given the increase in HPV positive OPC there is current interest in generating reliable data for prevalence of oral HPV infection and monitoring trends, so as to better understand aetiology of infection and progression to cancer.
Greater knowledge of the prevalence of oral HPV infection is particularly timely given the ongoing debate regarding HPV vaccination in males. 3 A recent meta-analysis of 29 studies worldwide, with over 22,000 participants, found an overall prevalence of 2.7% oral HR-HPV infection. 4 The majority of studies reporting oral HR-HPV prevalence have been performed in North or South America and there is a lack of published data available about the prevalence of oral HR-HPV in the UK. The Scottish HOPSCOTCH trial collected oral rinse and gargle samples from 380 participants and reported a prevalence of 3.7% oral HR-HPV infection in males and females aged 16-69, recruited through dental practices. 5 The only study previously performed in London, England reported sex with men. 6 The lack of information about oral HR-HPV prevalence for the English population constitutes an important knowledge gap.
Sexual behaviour and smoking status are considered to be the most important predictors of infection with oral HR-HPV. 4,7,4 8 Additionally, there is evidence that the vitamin folate may influence the risk of HPV-linked cancers through mechanisms relating to HPV infection and persistence. 9 Studies by our group and others have shown that low red cell folate status is associated with an increased risk of cervical HPV infection 10 11 , HPV persistence 9 and cervical intraepithelial neoplasia or invasive cervical cancer. 11 The association between oral HR-HPV infection and folate status has not previously been studied. Here we have investigated the prevalence of oral HR-HPV infection in participants in Sheffield, England, and explored associated risk factors and folate status.
METHODS

Study design
Participants aged between 18-60 yr were chosen based on available data from the United
States National Health and Nutrition Examination Survey (NHANES) study and power calculations performed to estimate study size based on the reported HR-HPV prevalence of 3.7%. 8 A case-control study design was chosen to compare folate status of HR-HPV positive participants matched to three HR-HPV negative control samples; matched for gender, age and smoking status.
Recruitment
Seven hundred men and women between 18-60 yr were recruited between April 2013 and August 2014 in Sheffield, UK. Sheffield is a city with a population of 570,000, of which approximately 50,000 are students attending two Universities. Sheffield has lower salaries for those in full time employment compared to the national average however this is seen across Participants were recruited from across Sheffield including: university students (179), university and hospital staff (163), dental hospital patients (13) , Sexual Health Sheffield patients (122) and the general public (223). Recruitment was achieved through university and hospital email distribution lists, posters, patient letters, newspaper adverts and on site recruitment at hospital locations.
All participants gave written, informed consent according to protocols approved by the NHS Humber Bridge Research Ethics Committee (REC reference 13/YH/0060). The study was registered with the UK Clinical Research Network (UKCRN ID 14106). Exclusion criteria included previous HPV vaccination, oral lesions, previous diagnosis of oral cancer and inability to understand and/or comply with study procedures.
Sampling and questionnaire
Participants were asked to complete a questionnaire relating to smoking status, alcohol consumption and sexual history adapted from a previous trial. 12 Each participant provided a finger-prick blood sample for the analysis of whole blood folate. Oral mucosal buccal epithelial cell samples were collected by brush biopsy (Orcellex ® soft brush, Rovers Medical Devices, The Netherlands) and frozen buccal cell and blood samples were transported to the Rowett Institute of Nutrition and Health, Aberdeen, UK, for the measurement of folate using the SimulTRAC-S radioassay kit, (MP Diagnostics, supplied by Anachem Ltd Bedford, UK).
Oral exfoliated cells were collected for HPV detection by thirty-second rinse and gargle with saline. HPV detection was carried out in the Cytology Department of the Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, using the Linear Array HPV genotyping assay on a Roche platform, presence of β-globulin was used as a biomarker of sample validity. Samples were tested for the presence of HR-HPV subtypes 16 
Statistical analysis
All statistical analysis was performed using SPSS version 21. Logistic regression analysis was conducted to determine the influence of age, gender, smoking, alcohol consumption and sexual behaviour, on risk of being HR-HPV positive, using data from the whole dataset.
Additionally, every person who tested HR-HPV positive was matched with three individuals who tested HR-HPV negative, matching for age, gender and smoking status. Logistic regression analysis was used to determine the influence of whole blood folate and buccal cell folate on likelihood of being HR-HPV positive, using data from the whole dataset and, separately, data from matched samples.
Patient and public involvement
No participants were involved with the study design.
RESULTS
The characteristics of participants recruited to the study are shown in 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Former smokers were significantly more likely to be HR-HPV positive compared to those who had never smoked; while the sample size for current smokers was insufficient to judge risk for this population. Participants who had a greater number of sexual partners (more than six) were significantly more likely to be HR-HPV positive compared to those with fewer than six sexual partners. Participants with 6-10 oral sexual partners were also at increased risk of HR-HPV compared to those reporting fewer oral sexual partners. Participants reporting more than 11 oral sexual partners had an increased odds ratio (OR 2.46, 95% CI 0.47;12.92) for HR-HPV positivity however this did not reach statistical significance.
Whole blood folate in participants who tested HR-HPV positive was (mean ± SD), 175. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  p  e  e  r  r  e  v  i  e  w  o  n  l  y   9 gender, age and smoking status (Figure 1) ). Neither whole blood folate nor buccal cell folate were significantly associated with risk of oral HR-HPV infection.
DISCUSSION
The prevalence of oral HR-HPV infection observed in this study (2.2%) was in line with the global review and meta-analysis performed by Shigeishi and Sugiyama which reported 2.7%
oral HR-HPV infection. 4 However, the prevalence in this study was lower than two previous studies performed in the UK that reported a prevalence of 3.7% in a Scottish cohort of 380 participants attending dental clinics 5 and a prevalence of 5.9% in men who have sex with men (MSM) in London. 6 This variation in prevalence was not surprising given the differences in study populations. Our cohort had a higher proportion of participants under the age of 25 compared to the participants in Scotland and it has previously been shown there is a weak association between increasing age and oral HR-HPV prevalence. 8 The London study population was made up of MSM and the prevalence reported (5.9%) was comparable to previous reports of oral HR-HPV infection in MSM (6.0%). 4 A limitation of this study, and indeed of the many studies measuring HPV prevalence globally, is the diversity of HPV detection methods used and the HR-HPV subtypes included in detection. The assay chosen for this study was the Roche linear array HPV genotype assay that detects all 13 class 1 carcinogen HPV subtypes. The Roche linear array system was the most commonly used assay in the studies analysed in the recent meta-analysis (8/29 studies), even so the HPV subtypes detected in each of these studies varied greatly. 4 Many studies have limited their analysis to HPV 16 and HPV 18 infection given their dominance in HPV infected OPC (and cervical neoplasia) cases, however, the data presented here showed that HPV16 and 18 were limited to just 5 participants, whereas the other HR-HPV subtypes were detected in 10 participants.
The current HPV vaccine administered to girls through the UK National Health Service is Previous studies have shown a strong association between oral sexual experience, number of oral sexual partners and oral HR-HPV infection. 4, 14 The results from this study confirmed this association as it showed a significantly increased risk of oral HR-HPV infection in those reporting 6-10 oral sexual partners compared to those with fewer than six oral sexual partners; those reporting more than 11 oral sexual partners showed a non-significant increase in risk;
possibly due to the smaller sample size. This study also showed that total number of number of sexual partners was greater for people with oral HR-HPV infection, again in line with previous studies. 4, 14 Smoking is reported to be associated with an increased risk of HR-HPV infection, with a strong association in females. 4 Furthermore, smoking may increase the likelihood of an oral HR-HPV infection persisting. 15 Fakhry et al., previously showed a strong dose-response association between tobacco exposure and oral infection with HPV-16 16 , however, in our study current smokers were not shown to be at significantly greater risk of HR-HPV infection.
This may reflect in part the lower prevalence of smoking in this UK population (only 16% described themselves as current smokers) compared with the US population described in the Fakhry study (80% reported using tobacco in the previous 5 days). 16 This study did however demonstrate that former smokers were more likely to have oral HR-HPV infection compared to those who had never smoked.
Alcohol use was not associated with incidence of oral HR-HPV infection in our study and this is in line with other findings. 4 The relationship between alcohol and HR-HPV infection appears complex with one study showing a weak association with oral HR-HPV infection and 8 and another demonstrating that those who had ever consumed alcohol were at a lower risk of oral HPV infection than never drinkers. 17 Poor folate status has been linked with cancer at various sites including oral cavity and pharyngeal cancers 18 , and epidemiological data are supported by plausible mechanisms.
Importantly there are also some data to suggest that poor folate status may increase the likelihood of acquiring and retaining an HPV infection. 9 Furthermore, it has been shown that low folate conditions increased HPV integration into the keratinocyte host genome and reduced viral capsid production in human keratinocytes in vitro. 19 In this study we found no association between whole blood folate concentration, buccal folate concentration and oral HR-HPV infection. This may indicate there is no causal association between folate status and oral HR-HPV infection but the small number of participants testing positive for oral HR-HPV infection in our sample will have reduced the likelihood of detecting such an association.
There are limitations to the study, not least the difficulty of drawing conclusions about risk factors for oral HR-HPV infection when the prevalence was low and as a result confidence intervals are broad. In addition to this self-reported sexual, smoking and alcohol behaviors may not be accurate.
To our knowledge this is the first study to examine the prevalence of oral HR-HPV infection in adult men and women in England. The prevalence is low and the data suggest that oral infection with high-risk types is associated with tobacco use and sexual behaviour.
Authorship
The study was conceived and designed by HJP and CM, with contribution by VH. VH took charge of the day-to-day running of the project; recruitment and collection of informed consent was the responsibility of VH and KD'A; KD'A and VH ran all clinics, collected and processed oral samples. SD and NJH developed, optimised and ran folate Participants Seven hundred participants, aged 18-60 yr, were recruited from university students (n=179), university and hospital staff (n=163), dental hospital patients (n=13), Sexual Health Sheffield patients (n=122) and the general public (n=223). 
Interventions
Strengths and limitations of this study
• This is the first report of the prevalence of oral HR-HPV infection in men and women in England.
• The low prevalence of infection may confer only limited ability to confidently determine risk factors for oral HR-HPV infection and associations with folate status.
• Self-reported sexual, smoking and alcohol behaviours were collected using nonvalidated questionnaires and as such may not be accurate.
INTRODUCTION
Greater knowledge of the prevalence of oral HPV infection is particularly timely given the ongoing debate regarding HPV vaccination in males. 3 A recent meta-analysis of 29 studies worldwide, with over 22,000 participants, found an overall prevalence of 2.7% oral HR-HPV infection. 4 The majority of studies reporting oral HR-HPV prevalence have been performed in North or South America and there is a lack of published data available about the prevalence of oral HR-HPV in the UK. The Scottish HOPSCOTCH trial collected oral rinse and gargle samples from 380 participants and reported a prevalence of 3.7% oral HR-HPV infection in males and females aged 16-69, recruited through dental practices. 5 The only study previously performed in London, England reported
5.9% HR-HPV prevalence in human immunodeficiency virus (HIV) negative men who have
sex with men. 6 The lack of information about oral HR-HPV prevalence for the English population constitutes an important knowledge gap.
Sexual behaviour and smoking status are considered to be the most important predictors of infection with oral HR-HPV. 4, 7, 8 Additionally, there is evidence that the vitamin folate may influence the risk of HPV-linked cancers through mechanisms relating to HPV infection and persistence. 9 Studies by our group and others have shown that low red cell folate status is associated with an increased risk of cervical HPV infection 10, 11 , HPV persistence 9 and cervical intraepithelial neoplasia or invasive cervical cancer. 11 The association between oral HR-HPV infection and folate status has not previously been studied. Here we have investigated the prevalence of oral HR-HPV infection in participants in Sheffield, England, and explored associated risk factors and folate status.
METHODS
Study design
A case-control study design was used to compare folate status of HR-HPV positive participants matched to three HR-HPV negative control samples; matched for gender, age and smoking status. The sample size for the case-control study was based on our data from a nested case-control study of cervical cell folate concentration in women with HR-HPV infection that persists (cases) and those in whom the virus is cleared (controls) over 6 months 12 . We detected an almost two-fold difference in mean folate concentration in cervical cells from cases vs controls (mean (SD) 5.4, ± 4.83 ng folate/ mg protein in cases versus 2.8,
±2.70 controls). We calculated that 50 cases with 150 controls would allow us to detect a 45
% difference between cases (oral HR-HPV positive) and controls (oral HR-HPV negative) in oral mucosal buccal epithelial cell folate, with a power of 80% and P < 0.05. 
Recruitment
Seven hundred men and women between 18-60 yr were recruited between April 2013 and August 2014 in Sheffield, UK. Sheffield is a city with a population of 570,000, of which approximately 50,000 are students attending two Universities. Sheffield has lower salaries for those in full time employment compared to the national average however this is seen across many cities in the north of England. While no socioeconomic data were collected as part of this study it is expected the results are applicable to other northern English cities.
Participants were recruited from across Sheffield including: university students (179), university and hospital staff (163), dental hospital patients (13), Sexual Health Sheffield patients (122) and the general public (223). Recruitment was achieved through university and hospital email distribution lists, posters, patient letters, newspaper adverts and on site recruitment at hospital locations to obtain a diverse study population. 
Sampling and questionnaire
Participants were asked to complete a questionnaire relating to smoking status, alcohol consumption and sexual history adapted from a previous trial. 14 
Statistical analysis
Patient and public involvement
RESULTS
The characteristics of participants recruited to the study are shown in table 1, for all participants and according to HR-HPV status. Former smokers were significantly more likely to be HR-HPV positive compared to those who had never smoked (OR 3.12, 95% CI 1.07;9.15); while the sample size for current smokers was insufficient to judge risk for this population. Participants who had a greater number of sexual partners (more than six) were significantly more likely to be HR-HPV positive compared to those with fewer than six sexual partners (6-10 partners OR 5.93, 95% 
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The prevalence of oral HR-HPV infection observed in this study (2.2%) was in line with the global review and meta-analysis performed by Shigeishi and Sugiyama which reported 2.7% oral HR-HPV infection. 4 However, the prevalence in this study was lower than two previous studies performed in the UK that reported a prevalence of 3.7% in a Scottish cohort of 380 participants attending dental clinics 5 and a prevalence of 5.9% in men who have sex with men (MSM) in London. 6 This variation in prevalence was not surprising given the differences in study populations. Our cohort had a higher proportion of participants under the age of 25 compared to the participants in Scotland and it has previously been shown there is a weak association between increasing age and oral HR-HPV prevalence. 8 The London study population was made up of MSM and the prevalence reported (5.9%) was comparable to previous reports of oral HR-HPV infection in MSM (6.0%). 4 These prevalence data could be considered relevant to English populations, however, given the diversity in oral HPV prevalence rates reported globally this cannot be generalised to the rest of the world.
A limitation of this study, and indeed of the many studies measuring HPV prevalence globally, is the diversity of HPV detection methods used and the HR-HPV subtypes included in detection. The assay chosen for this study was the Roche linear array HPV genotype assay that detects all 13 class 1 carcinogen HPV subtypes. The Roche linear array system was the most commonly used assay in the studies analysed in the recent meta-analysis (8/29 studies), even so the HPV subtypes detected in each of these studies varied greatly. 4 Many studies have limited their analysis to HPV 16 and HPV 18 infection given their dominance in HPV infected OPC (and cervical neoplasia) cases, however, the data presented here showed that HPV16 and 18 were limited to just 5 participants, whereas the other HR-HPV subtypes were detected in 10 participants.
The current HPV vaccine administered to girls through the UK National Health Service is protective against four HPV strains (16, 18, 6 and 11). The data presented here highlight the need for future studies which investigate the relative prevalence and risk of OPC development Previous studies have shown a strong association between oral sexual experience, number of oral sexual partners and oral HR-HPV infection. 4 16 The results from this study confirmed this association as it showed a significantly increased risk of oral HR-HPV infection in those reporting 6-10 oral sexual partners compared to those with fewer than six oral sexual partners; those reporting more than 11 oral sexual partners showed a non-significant increase in risk;
possibly due to the smaller sample size. This study also showed that total number of sexual partners was greater for people with oral HR-HPV infection, again in line with previous studies. 4, 16 Smoking is reported to be associated with an increased risk of HR-HPV infection, with a strong association in females. 4 Furthermore, smoking may increase the likelihood of an oral HR-HPV infection persisting. 17 Fakhry et al., previously showed a strong dose-response association between tobacco exposure and oral infection with HPV-16 18 , however, in our study current smokers were not shown to be at significantly greater risk of HR-HPV infection.
This may reflect in part the lower prevalence of smoking in this UK population (only 16% described themselves as current smokers) compared with the US population described in the Fakhry study (80% reported using tobacco in the previous 5 days). 18 This study did however demonstrate that former smokers were more likely to have oral HR-HPV infection compared to those who had never smoked.
Alcohol use was not associated with incidence of oral HR-HPV infection in our study and this is in line with other findings. 4 The relationship between alcohol and HR-HPV infection appears complex with one study showing a weak association with oral HR-HPV infection and heavy drinking (before accounting for sexual behaviour) 8 and another demonstrating that 20 , and epidemiological data are supported by plausible mechanisms.
Importantly there are also some data to suggest that poor folate status may increase the likelihood of acquiring and retaining an HPV infection. 9 Furthermore, it has been shown that low folate conditions increased HPV integration into the keratinocyte host genome and reduced viral capsid production in human keratinocytes in vitro. 21 In this study we found no association between whole blood folate concentration, oral mucosal buccal epithelial cell folate concentration and oral HR-HPV infection. This may indicate there is no causal association between folate status and oral HR-HPV infection but the small number of participants testing positive for oral HR-HPV infection in our sample will have reduced the likelihood of detecting such an association.
There are limitations to the study, not least the difficulty of drawing conclusions about risk factors for oral HR-HPV infection when the prevalence was low and as a result confidence intervals are broad. In addition to this questionnaires were not validated and relied on selfreported sexual, smoking and alcohol behaviors, which may not be accurate.
Authorship
The study was conceived and designed by HJP and CM, with contribution by VH. VH took charge of the day-to-day running of the project; recruitment and collection of informed consent was the responsibility of VH and KD'A; KD'A and VH ran all clinics, collected and processed oral samples. SD and NJH developed, optimised and ran folate Figure 1 Full questionnaire administered to all participants. 
Diet, HPV and Oral Health Questionnaire
As part of the research study you agreed to take part in, there are some questions we would like to ask you. It is well known that smoking and drinking alcohol alter the environment in your mouth, so we would like to find out how much you smoke and how much alcohol you drink.
There is also recent evidence that a virus called HPV alters the cells within your mouth; HPV can be sexually transmitted. To better understand whether there is a link between oral HPV prevalence and sexual history we would like to ask you a few questions about your sexual history. While we understand this is a very sensitive topic, we would appreciate it if you would be willing to answer the following questions. The information gathered in this questionnaire is very important to the study. If you would prefer not to answer some of the questions please leave them blank.
Do not put your name or contact details on this form. It will only be linked to the samples you provided by the study ID number. Your samples will only be labelled with the study ID number.
Only the research team has access to this questionnaire and will keep any information contained in it confidential. Once you have completed the questionnaire please put it in the envelope provided and give it to a member of the research team. Do not put your name or other personally identifying information on it. If you have any questions regarding this questionnaire please ask a member the research team, who will be happy to help.
Many thanks.
Please complete the following details:
Age .............
Male Female
Smoking:
1) Please tick the box which best describes you smoking status:
Current smoker
Former smoker
Never smoked Please place this in the envelope provided and hand it to the study team.
For free confidential information and advice on sexual health call:
NHS Sexual Health Helpline 0800 567 123
For advice and counselling on relationships and sex call:
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